State Street Corp Greenwich Life Sciences, Inc. Transaction History
State Street Corp
- $2.41 Trillion
- Q3 2024
A detailed history of State Street Corp transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, State Street Corp holds 71,408 shares of GLSI stock, worth $921,163. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,408
Previous 68,403
4.39%
Holding current value
$921,163
Previous $1.18 Million
13.05%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GLSI
# of Institutions
38Shares Held
1.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$3.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA274KShares$3.53 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA134KShares$1.72 Million0.0% of portfolio
-
Credit Agricole S A87KShares$1.12 Million0.01% of portfolio
-
Northern Trust Corp Chicago, IL74.5KShares$961,0500.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $166M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...